PLRX
Pliant Therapeutics Inc
NASDAQ: PLRX · HEALTHCARE · BIOTECHNOLOGY
$1.21
+0.00% today
Updated 2026-04-29
Market cap
$74.92M
P/E ratio
—
P/S ratio
3,071.82x
EPS (TTM)
$-2.43
Dividend yield
—
52W range
$1 – $2
Volume
0.6M
WallStSmart proprietary scores
30
out of 100
Grade: F
Strong Sell
Investment rating
3.7
Growth
D5.0
Quality
C+3.0
Profitability
D5.0
Valuation
C+—/9
Piotroski F-Score
—
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →200 stocks currently score above 75
Price targets
Analyst target
$2.67
+120.41%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
1 Strong Buy0 Buy5 Hold0 Sell1 Strong Sell
Price chart
X-Ray snapshot
Strengths
Insufficient data
Risks
- Thin margins at 0.00%
- Negative free cash flow $-17.79M
- Revenue declining -100.00% QoQ
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $9.69M | $1.58M | $0.00 | $0.00 | $0.00 |
| Net income | $-123.32M | $-161.34M | $-210.30M | $-149.34M | $-23.58M |
| EPS | — | — | — | — | $-2.43 |
| Free cash flow | $-96.39M | $-117.28M | $-159.35M | $-128.71M | $-17.79M |
| Profit margin | -1,273.32% | -10,211.14% | — | — | — |
Peer comparison
Smart narrative
Pliant Therapeutics Inc trades at $1.21. Our Smart Value Score of 30/100 indicates the stock is weak.
Frequently asked questions
What is Pliant Therapeutics Inc's stock price?
Pliant Therapeutics Inc (PLRX) trades at $1.21.
Is Pliant Therapeutics Inc overvalued?
Smart Value Score 30/100 (Grade F, Strong Sell).
What is the price target of Pliant Therapeutics Inc (PLRX)?
The analyst target price is $2.67, representing +120.4% upside from the current price of $1.21.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio3,071.82x
ROE-61.60%
Beta1.25
50D MA$1.29
200D MA$1.43
Shares out0.06B
Float0.06B
Short ratio—
Avg volume0.6M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—